Jiangxi Synergy Pharmaceutical Co Ltd
SZSE:300636
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
J
|
Jiangxi Synergy Pharmaceutical Co Ltd
SZSE:300636
|
CN |
|
Urovo Technology Co Ltd
SZSE:300531
|
CN |
|
TCPL Packaging Ltd
NSE:TCPLPACK
|
IN |
|
S
|
S2Medical AB (publ)
STO:S2M
|
SE |
|
M
|
Malakoff Corp Bhd
KLSE:MALAKOF
|
MY |
|
Umanis SA
F:EUA2
|
FR |
|
Adani Total Gas Ltd
NSE:ATGL
|
IN |
|
S
|
Solar A/S
XBER:ZVR
|
DK |
|
H
|
Hallmark Financial Services Inc
XBER:SSB
|
US |
|
R
|
Reeder Teknoloji Sanayi ve Ticaret AS
IST:REEDR.E
|
TR |
|
Galliford Try Holdings PLC
LSE:GFRD
|
UK |
|
C
|
Cargotec Corp
SWB:C1C
|
FI |
|
H
|
Hui Lyu Ecological Technology Groups Co Ltd
SZSE:001267
|
CN |
|
Zhejiang Crystal-Optech Co Ltd
SZSE:002273
|
CN |
|
J
|
Jinling Pharmaceutical Co Ltd
SZSE:000919
|
CN |
|
Intercontinental Exchange Inc
NYSE:ICE
|
US |
|
C
|
China Regenerative Medicine International Ltd
HKEX:8158
|
HK |
|
MPLX LP
NYSE:MPLX
|
US |
|
COFCO Biotechnology Co Ltd
SZSE:000930
|
CN |
|
L
|
La Comer SAB de CV
BMV:LACOMERUBC
|
MX |
|
E
|
Enghouse Systems Ltd
OTC:EGHSF
|
CA |
|
S
|
San Miguel Corp
XPHS:SMC
|
PH |
|
D
|
Deutsche Konsum REIT-AG
XETRA:DKG
|
DE |
|
Banco ABC Brasil SA
BOVESPA:ABCB4
|
BR |
Wall Street
Price Targets
Price Targets Summary
Jiangxi Synergy Pharmaceutical Co Ltd
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Jiangxi Synergy Pharmaceutical Co Ltd's stock price target?
Not Available
Jiangxi Synergy Pharmaceutical Co Ltd doesn't have any price targets made by Wall Street professionals.
What is Jiangxi Synergy Pharmaceutical Co Ltd's Revenue forecast?
Projected CAGR
14%
For the last 9 years the compound annual growth rate for Jiangxi Synergy Pharmaceutical Co Ltd's revenue is 12%. The projected CAGR for the next 3 years is 14%.
What is Jiangxi Synergy Pharmaceutical Co Ltd's Operating Income forecast?
Projected CAGR
22%
For the last 9 years the compound annual growth rate for Jiangxi Synergy Pharmaceutical Co Ltd's operating income is 4%. The projected CAGR for the next 3 years is 22%.
What is Jiangxi Synergy Pharmaceutical Co Ltd's Net Income forecast?
Projected CAGR
17%
For the last 9 years the compound annual growth rate for Jiangxi Synergy Pharmaceutical Co Ltd's net income is 6%. The projected CAGR for the next 3 years is 17%.
